Fenwick has advised Scribe Therapeutics. Latham & Watkins has advised the underwriters. Scribe Therapeutics Inc., a clinical-stage biotechnology company specializing in in vivo CRISPR technologies, has...
Scribe Therapeutics Completes $155.51 Million Initial Public Offering and Private Placement
Eli Lilly Acquires AtaiBeckley to Expand Mental Health Treatment Pipeline in $3.8 Billion Deal
Ropes & Gray has advised Eli Lilly and Company. Latham & Watkins has advised AtaiBeckley Inc. Eli Lilly and Company (NYSE: LLY) has entered into a...
Thermo Fisher to Sell Microbiology Business to Astorg for $1.075 Billion
Cravath, Swaine & Moore LLP, Axinn, Veltrop & Harkrider LLP, Hogan Lovells, and Perella Weinberg Partners and Wells Fargo have advised Thermo Fisher Scientific. Latham &...
Capitol Meridian Partners and Stellex Acquire Beaufort from Survitec
Latham & Watkins has advised Capitol Meridian Partners and Stellex Capital Management. Proskauer has also advised Stellex Capital Management. Capitol Meridian Partners and Stellex Capital Management...
AIR Limited and Cantor Equity Partners III Announce $1.749 Billion Business Combination
Latham & Watkins has advised AIR Limited. DLA Piper has advised Cantor Equity Partners III. Wilmer Cutler Pickering Hale and Dorr has advised Barclays. AIR Limited,...
atai Life Sciences Merges with Beckley Psytech
NautaDutilh and Latham & Watkins advised atai Life Sciences, while Debevoise & Plimpton advised Guggenheim Securities as financial advisor to atai Life Sciences. atai Life Sciences...
Platinum Equity’s Acquisition of a Controlling Stake in Inventia Healthcare
Latham Watkins served as international legal counsel alongside Trilegal as India legal counsel for Platinum Equity in the transaction, while Kirkland & Ellis provided financing counsel...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Amphenol Corp.’s $2.025 Billion Acquisition of Carlisle Interconnect Technologies
Kirkland & Ellis is advising Carlisle Companies Incorporated on the transaction, and Latham & Walkins is advising Amphenol Corporation. Amphenol Corporation (NYSE: APH), a leading global...
Sanofi, AstraZeneca and Sobi’s Streamlining of Nirsevimab Contractual Arrangements
Latham & Watkins represented Sobi in the transaction. Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus (nirsevimab) in the United...
Harps Global’s Acquisition of a Medical Division from Semperit
Schoenherr and Latham & Watkins advised Harps Global on the deal. Harps Global PTE. LTD executed the acquisition of the medical business division (Sempermed) from Austrian...
Goldman Sachs Asset Management’s Acquisition of Controlling Stake in Norgine Europe
Latham & Watkins has advised Norgine Europe B.V. on the deal. Allen & Overy and White & Case have advised Goldman Sachs Asset Management Division. Norgine...